Flavonoids · Apigenin

Constituents of Passiflora incarnata (apigenin, orientin, vitexin) interact with OATP2B1 and OATP1A2 transporters, potentially altering uptake of other compounds

The study found that apigenin, orientin, and vitexin from Passiflora incarnata inhibit and are substrates of OATP2B1 and OATP1A2 transporters, while valerenic acid from Valeriana officinalis only interacts with OATP2B1. Commercially available P. incarnata preparations also inhibited transporter-mediated uptake of estrone 3-sulfate, suggesting these constituents may affect the pharmacokinetics of other drugs relying on these transporters.

1 min readUpdated Jul 7, 20260 RCTsView structured evidence →
Evidence Score24/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.

Constituents of Passiflora incarnata (apigenin, orientin, vitexin) interact with OATP2B1 and OATP1A2 transporters, potentially altering uptake of other compounds The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 24/100 (low).

The Claim

Constituents of Passiflora incarnata (apigenin, orientin, vitexin) interact with OATP2B1 and OATP1A2 transporters, potentially altering uptake of other compounds

This conclusion is most relevant to: Madin-Darby canine kidney cells overexpressing OATP2B1 or OATP1A2 (in vitro cell model).

What the Research Shows

The conclusion draws on 1 linked study. Highlights from the cited literature:

  • Constituents of Passiflora incarnata, but Not of Valeriana officinalis, Interact with the Organic Anion Transporting Polypeptides (OATP)2B1 and OATP1A2. (Planta medica, 2022) —

How It Works

The proposed biological pathway:

  • Constituents of P. incarnata (apigenin, orientin, vitexin) inhibit OATP2B1 and OATP1A2-mediated uptake of sulfated steroids
  • Competitive counterflow experiments show orientin is a substrate of both transporters, apigenin of OATP1A2, and vitexin of OATP2B1
  • Commercially available P. incarnata preparations inhibit transporter-mediated estrone 3-sulfate uptake
  • HPLC-UV-MS confirms orientin and vitexin in these preparations, suggesting they contribute to transporter interaction

Who Might Benefit

Evidence fit by population:

  • Madin-Darby canine kidney cells overexpressing OATP2B1 or OATP1A2 (in vitro cell model)

Limitations & Caveats

Important context when interpreting this evidence:

  • In vitro cell model may not fully replicate in vivo human physiology
  • Only tested sulfated steroids as substrates; interactions with other compounds remain unknown

Frequently Asked Questions

Do Passiflora incarnata constituents affect drug transport?

Yes, apigenin, orientin, and vitexin inhibit and are transported by OATP2B1 and OATP1A2, which could alter the uptake of other drugs or compounds that rely on these transporters.

What transporters are affected by Passiflora incarnata?

The study found interactions with organic anion transporting polypeptides OATP2B1 and OATP1A2.

Does Valeriana officinalis interact with these transporters?

Valerenic acid from Valeriana officinalis only interacted with OATP2B1, not OATP1A2, and was not identified as a substrate.

What methods were used to test transporter interaction?

The study used Madin-Darby canine kidney cells overexpressing OATP2B1 or OATP1A2, measuring cellular accumulation of sulfated steroids, followed by competitive counterflow experiments.

References

  1. 1.Schäfer AM, Gilgen PM, Spirgi C, Potterat O, Meyer Zu Schwabedissen HE. “Constituents of Passiflora incarnata, but Not of Valeriana officinalis, Interact with the Organic Anion Transporting Polypeptides (OATP)2B1 and OATP1A2..” Planta medica, 2022. PMID: 33511622 DOI: 10.1055/a-1305-3936
Disclaimer: This article is auto-generated from structured research data for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.